Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also received a Bachelor of Arts in journalism and was editor-in-chief of her college newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have 3 young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Rheumatoid Arthritis Advisor

Serum Chemerin Levels May Be a New Biomarker for Women With More Severe RA

Estie Mermelstein, MSN, FNP-BC

December 7, 2021

A study examines the relationship between serum chemerin and disease activity in women with rheumatoid arthritis (RA).

Rheumatoid Arthritis Advisor

Spinal Issues in Patients With RA Linked to Poor Disease Control

Estie Mermelstein, MSN, FNP-BC

November 3, 2021

Incidence of, and risk factors for, lumbar lesions in RA are examined in a longitudinal study.

Senior woman with joint pain in her hand

Rheumatoid Arthritis Advisor

Joint Swelling in Rheumatoid Arthritis Tends to Recur

Estie Mermelstein, MSN, FNP-BC

November 3, 2021

Does local joint swelling recur in the same joints in patients with rheumatoid arthritis?

Rheumatoid Arthritis Advisor

Filgotinib Plus Methotrexate Treatment Superior for Patients With RA

Estie Mermelstein, MSN, FNP-BC

October 21, 2021

The efficacy and safety of filgotinib in methotrexate-naïve patients with RA with poor prognostic factors is examined.

Rheumatoid Arthritis Advisor

Prophylaxis Protocol Decreases PCP Incidence in Patients With RA Treated With b/tsDMARDs

Estie Mermelstein, MSN, FNP-BC

October 21, 2021

A prophylaxis regime to prevent pneumocystis pneumonia in patients with RA treated with b/tsDMARDs is reported.

Psoriatic Arthritis

Biologic Agents Reduce Psoriatic Arthritis Incidence

Estie Mermelstein, MSN, FNP-BC

October 13, 2021

The effect of psoriasis treatment with biologic agents and incidence of psoriatic arthritis is examined.

Risk of stroke after herpes zoster in patients with autoimmune diseases

Rheumatoid Arthritis Advisor

Increased Herpes Zoster Risk in Patients With RA Treated With Biologic DMARDs

Estie Mermelstein, MSN, FNP-BC

October 7, 2021

Event and incidence rates of herpes zoster in patients with RA treated with biologic, tsDMARDs are compared.

General Rheumatology

Decreased Seroconversion Rates After COVID-19 Vaccination in Patients With Immune-Mediated Inflammatory Diseases

Estie Mermelstein, MSN, FNP-BC

October 1, 2021

Investigators conducted a systemic review to assess the effects of various medications on seroconversion rates following SARS-CoV-2 vaccination in patients with immune mediated inflammatory disease.

General Medicine

Therapeutic-Dose Heparin Improves Survival Outcomes in Patients Hospitalized With COVID-19

Estie Mermelstein, MSN, FNP-BC

September 15, 2021

Investigators conducted a multiplatform trial to compare the effects of therapeutic-dose heparin with standard care thromboprophylaxis for the treatment of patients hospitalized with moderate COVID-19.

General Medicine

Adverse Effects Among Vaccinated Individuals Reported in the COVID Symptom Study App

Estie Mermelstein, MSN, FNP-BC

September 1, 2021

Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.

Next post in General Medicine